Literature DB >> 3373022

Use of purified parasite proteins from Leishmania donovani for the rapid serodiagnosis of visceral leishmaniasis.

C L Jaffe1, M Zalis.   

Abstract

Serodiagnosis of visceral leishmaniasis (VL) due to Leishmania donovani by using crude parasite antigen is complicated in many endemic areas because of cross-reactions with sera from humans with Chagas' disease. We used affinity-purified parasite proteins to develop a direct dot-blot assay for VL. Double-blind tests were carried out on sera from 40 patients with well-documented VL, from controls in endemic areas, and from patients with other diseases. Using gp70-2, 36 (90.0%) of 40 sera from patients with kala azar were correctly diagnosed; 1 (1.2%) of 86 sera from patients without kala azar was misdiagnosed. With dp72, 21 (100%) of 21 sera from patients with VL were correctly identified; 5 (7.0%) of 71 negative sera were misdiagnosed. None of the 18 sera from patients with Chagas' disease reacted positively against gp70-2. Our assay is rapid, simple, and specific and represents a new method for reliably diagnosing and monitoring VL.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3373022     DOI: 10.1093/infdis/157.6.1212

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

Review 1.  Serodiagnosis of parasitic diseases.

Authors:  S E Maddison
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

2.  Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis.

Authors:  E Ghedin; W W Zhang; H Charest; S Sundar; R T Kenney; G Matlashewski
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

3.  Autoantibody production by patients infected with Leishmania.

Authors:  S Argov; C L Jaffe; M Krupp; H Slor; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

4.  Performance of immunoblotting in diagnosis of visceral Leishmaniasis in human immunodeficiency virus-Leishmania sp.-coinfected patients.

Authors:  G Santos-Gomes; S Gomes-Pereira; L Campino; M D Araújo; P Abranches
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

5.  ELISA and western blotting for the detection of Hsp70 and Hsp83 antigens of Leishmania donovani.

Authors:  Jaspreet Kaur; Sukhbir Kaur
Journal:  J Parasit Dis       Date:  2012-07-03

6.  Immunoblot analysis of the humoral immune response to Leishmania donovani infantum polypeptides in human visceral leishmaniasis.

Authors:  L Rolland-Burger; X Rolland; C W Grieve; L Monjour
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

7.  Cross-reactivity studies and differential serodiagnosis of human infections caused by Trypanosoma cruzi and Leishmania spp; use of immunoblotting and ELISA with a purified antigen (Ag163B6).

Authors:  E L Malchiodi; M G Chiaramonte; N J Taranto; N W Zwirner; R A Margni
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

Review 8.  Leishmaniases of the New World: current concepts and implications for future research.

Authors:  G Grimaldi; R B Tesh
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

9.  Diagnosis of visceral leishmaniasis by enzyme-linked immunosorbent assay using urine samples.

Authors:  Mohammad Zahidul Islam; Makoto Itoh; S M Shamsuzzaman; Rusella Mirza; Farzana Matin; Iftikhar Ahmed; A K M Shamsuzzaman Choudhury; M Akram Hossain; Xu-Guang Qiu; Nilufar Begam; Masato Furuya; Judson L Leafasia; Yoshihisa Hashiguchi; Eisaku Kimura
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

10.  Synthetic peptide-based enzyme-linked immunosorbent assay for serodiagnosis of visceral leishmaniasis.

Authors:  C Fargeas; M Hommel; R Maingon; C Dourado; M Monsigny; R Mayer
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.